The deregulation and function of MALAT1 have been established in several solid tumors, including bladder cancer, lung cancer, colorectal cancer, esophageal squamous cell carcinoma, melanoma, breast cancer, and hepatocellular carcinoma14–20. This evidence concerns the gene MALAT1 and melanoma.